Chao Xingjuan 4

What Happened

• Chao Xingjuan, President, CEO and Director of Ceribell, exercised options and sold shares on May 5, 2026. She exercised 25,000 option shares at $4.70 each (total exercise cost $117,500) and sold a total of 39,000 common shares in open-market/private sales for aggregate proceeds of approximately $783,974. The sales were executed at weighted-average prices of about $20.09–$20.12 per share (range $19.77–$20.48).

Key Details

• Transaction date: May 5, 2026; Form 4 filed May 7, 2026 (within normal reporting window).
• Options exercised: 1,446 shares @ $4.70 ($6,796) and 23,554 shares @ $4.70 ($110,704) — total exercised = 25,000 shares; two additional derivative entries show $0 disposals tied to the exercises.
• Shares sold: 14,000 @ $20.12 ($281,680), 1,446 @ $20.12 ($29,094), 23,554 @ $20.09 ($473,200) — total sold = 39,000 shares; total sale proceeds ≈ $783,974. Weighted-average sale price reported; individual trades ranged $19.77–$20.48.
• Net proceeds before taxes/fees (sale proceeds minus exercise cost): ≈ $666,474.
• Footnotes: trades were made pursuant to a Rule 10b5-1 trading plan (F1); co-trustee/co‑beneficial ownership and disclaimer notes appear (F3, F4); one grant vests monthly (F5) and another option is fully vested/currently exercisable (F6).
• Shares owned after the transactions are not specified in the provided excerpt.

Context

• This sequence (exercising options then selling shares) is commonly a cashless or monetization event: options converted to common shares and many of those shares were sold the same day under a 10b5‑1 plan. Such transactions are routine for insiders exercising vested awards and do not, by themselves, indicate the insider’s view of the company’s outlook.